XML 57 R39.htm IDEA: XBRL DOCUMENT
v3.25.1

INTANGIBLE ASSETS AND GOODWILL (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract] |
SCHEDULE OF INTANGIBLE ASSETS | The Company’s intangible assets at December 31, 2024 consisted of the following: SCHEDULE OF INTANGIBLE ASSETS
|  | Weighted-average |  |  |  |  |  |  |  |  |  |  | Net |
|  | useful life |  |  |  |  | Accumulated |  |  |  |  |  | Carrying |
|  | (in years) |  | Cost |  |  | amortization |  |  | Impairment |  |  | value |
Patents |  | 19 years |  | $ | 611,000 |  |  | $ | (216,000 | ) |  | $ | (253,000 | ) |  | $ | 142,000 |
Licenses |  | 20 years |  |  | 50,000 |  |  |  | (36,000 | ) |  |  | - |  |  |  | 14,000 |
Trademarks |  | Indefinite |  |  | 230,000 |  |  |  | - |  |  |  | - |  |  |  | 230,000 |
Acquired NDAs |  | 14 years |  |  | 207,398,000 |  |  |  | (22,962,000 | ) |  |  | - |  |  |  | 184,436,000 |
Customer relationships |  | 7 years |  |  | 596,000 |  |  |  | (542,000 | ) |  |  | - |  |  |  | 54,000 |
Trade name |  | 5 years |  |  | 75,000 |  |  |  | (7,000 | ) |  |  | - |  |  |  | 68,000 |
Non-competition clause |  | 4 years |  |  | 50,000 |  |  |  | (50,000 | ) |  |  | - |  |  |  | - |
State pharmacy licenses |  | 25 years |  |  | 8,000 |  |  |  | (3,000 | ) |  |  | - |  |  |  | 5,000 |
|  |  |  | $ | 209,018,000 |  |  | $ | (23,816,000 | ) |  | $ | (253,000 | ) |  | $ | 184,949,000 |
The Company’s intangible assets at December 31, 2023 consisted of the following:
|  | Weighted-average |  |  |  |  |  |  |  |  |  |  | Net |
|  | useful life |  |  |  |  | Accumulated |  |  |  |  |  | Carrying |
|  | (in years) |  | Cost |  |  | amortization |  |  | Impairment |  |  | value |
Patents |  | 19 years |  | $ | 984,000 |  |  | $ | (253,000 | ) |  | $ | (276,000 | ) |  | $ | 455,000 |
Licenses |  | 20 years |  |  | 100,000 |  |  |  | (30,000 | ) |  |  | (22,000 | ) |  |  | 48,000 |
Trademarks |  | Indefinite |  |  | 281,000 |  |  |  | - |  |  |  | (82,000 | ) |  |  | 199,000 |
Acquired NDAs |  | 14 years |  |  | 170,353,000 |  |  |  | (11,300,000 | ) |  |  | - |  |  |  | 159,053,000 |
Customer relationships |  | 7 years |  |  | 596,000 |  |  |  | (516,000 | ) |  |  | - |  |  |  | 80,000 |
Trade name |  | 5 years |  |  | 75,000 |  |  |  | (5,000 | ) |  |  | - |  |  |  | 70,000 |
Non-competition clause |  | 4 years |  |  | 50,000 |  |  |  | (50,000 | ) |  |  | - |  |  |  | - |
State pharmacy licenses |  | 25 years |  |  | 8,000 |  |  |  | (7,000 | ) |  |  | - |  |  |  | 1,000 |
|  |  |  | $ | 172,447,000 |  |  | $ | (12,161,000 | ) |  | $ | (380,000 | ) |  | $ | 159,906,000 |
SCHEDULE OF AMORTIZATION EXPENSES FOR INTANGIBLE ASSETS | Amortization expense for intangible assets for the years ended December 31, 2024 and 2023 were as follows: SCHEDULE OF AMORTIZATION EXPENSES FOR INTANGIBLE ASSETS
|  | 2024 |  |  | 2023 |
|  | For the Years Ended December 31, |
|  | 2024 |  |  | 2023 |
Patents |  | $ | 56,000 |  |  | $ | 84,000 |
Licenses |  |  | 35,000 |  |  |  | 7,000 |
Acquired NDAs |  |  | 11,669,000 |  |  |  | 9,937,000 |
Customer relationships |  |  | 22,000 |  |  |  | 54,000 |
Trade name |  |  | 1,000 |  |  |  | - |
Amortization expense of intangible assets |  | $ | 11,783,000 |  |  | $ | 10,082,000 |
SCHEDULE OF ESTIMATED FUTURE AMORTIZATION EXPENSE | Estimated future amortization expense for the Company’s intangible assets at December 31, 2024 is as follows: SCHEDULE OF ESTIMATED FUTURE AMORTIZATION EXPENSE
Years ending December 31, |  |  |
2025 |  | $ | 16,903,000 |
2026 |  |  | 16,903,000 |
2027 |  |  | 16,612,000 |
2028 |  |  | 16,205,000 |
2029 |  |  | 16,095,000 |
Thereafter |  |  | 102,001,000 |
Intangible assets |  | $ | 184,719,000 |

X
- Definition Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life. + References No definition available. + Details
Name: | us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/350-30/tableOfContent Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/350-20/tableOfContent + Details
Name: | us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 55 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2 + Details
Name: | us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration